Table 4.
Investigator assessed RECIST v1.1 response by Dose Level.
| Level 1 | Level 2 | Level 3 | Level 4 | All Levels | |
|---|---|---|---|---|---|
| Complete Response (CR) | 0 | 0 | 0 | 0 | 0 |
| Partial Response (PR) | 0 | 0 | 0 | 0 | 0 |
| Stable Disease (SD) | 2/3 (66.7%) |
6/20 (30.0%) |
2/5 (40.0%) |
1/1 (100%) |
11/29 (38.0%) |
| Progressive Disease (PD) | 1/3 (33.3%) | 14/20 (70.0%) |
3/5 (60.0%) | 0 | 17/29 (62.0%) |
| Overall Response Rate (ORR) | 0 | 0 | 0 | 0 | 0 |
| Median Time to Progression (range) | 3.4 months (1.2-10.8) |
1.7 months (0.9-5.5) | 3.7 months (0.9-6.2) | Not Applicable | – |
| Median duration of Stable Disease | 7.1 months | 4.1 months | 4.9 months | Not Applicable | – |